SEC Form 4 · accession 0001632388-15-000007
Nexvet Biopharma plc · NVET
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Period of report
Feb 10, 2015
Accepted (ET)
Feb 10, 2015 · 3:11 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001618561
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Ordinary SharesF1,F2 | Feb 10, 2015 | C | 530,972 | — | A | 530,972 | D | |
| Ordinary SharesF3,F2 | Feb 10, 2015 | C | 242,400 | — | A | 773,372 | D | |
| Ordinary SharesF2 | Feb 10, 2015 | P | 100,000 | $10.00 | A | 873,372 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Series A Investment Preference SharesF1,F2 | — | Feb 10, 2015 | C | 530,972 | D | — | — | Ordinary Shares | 530,972 | 0 | D |
| Series B Preference SharesF3,F2 | — | Feb 10, 2015 | C | 242,400 | D | — | — | Ordinary Shares | 242,400 | 0 | D |
Explanation of responses
- F1Reflects automatic conversion of Series A Investment Preference Shares into ordinary shares on a one-for-one basis upon the completion of the initial public offering of Issuer's ordinary shares.
- F2Justin Epstein, as the authorized director of One Funds Management Limited, the trustee for Asia Pacific Healthcare Fund II, has voting and dispositive power with respect to these reported securities, but disclaims beneficial ownership thereof except to the extent of his pecuniary interest therein.
- F3Reflects automatic conversion of Series B Preference Shares into ordinary shares on a one-for-one basis upon the completion of the initial public offering of Issuer's ordinary shares.